Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06865859

Single Cell Landscape of HBV-related Acute-on-chronic Liver Failure Patients

Single-cell Landscape of Immunological Responses in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure

Status
Recruiting
Phase
Study type
Observational
Enrollment
21 (estimated)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aimed to profile the peripheral blood immune cells of patients with HBV related acute-on-chronic liver failure using single-cell RNA sequencing to reveal the immunopathological mechanisms of HBV related acute-on-chronic liver failure.

Detailed description

Acute-on-chronic liver failure (ACLF) is a complex clinical syndrome characterized by acute deterioration of liver function in patients with chronic liver disease, exhibiting liver and extrahepatic organ failure and a high short-term mortality. Immune imbalance plays an important role in the progression of HBV-related ACLF. Further investigation of the immune cell characteristics of HBV-related ACLF is helpful to understand its pathogenesis, and may provide reference for the effective therapeutic agent. Single-cell RNA sequencing (scRNA-seq) is the quantitative analysis of transcription at the single-cell level, which could provide systematic analyses of transcriptomic profiles, infer cell-cell interactions. This study will combine single cell transcriptomics and molecular biological experiment to elucidate the immunopathological cell states associated with HBV-related chronic liver disease vs. ACLF.

Conditions

Timeline

Start date
2023-11-01
Primary completion
2025-05-01
Completion
2025-05-01
First posted
2025-03-10
Last updated
2025-03-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06865859. Inclusion in this directory is not an endorsement.